4 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
Follow Lupron: new trials by email Literature Review of Lupron trials Research Report on Lupron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer Behavioral Dietary Intervention, Counseling, Educational Intervention - Prostate Adenocarcinoma | Phase 2 | Terminated | University of California, San Francisco | 57 | 2014-06-16 | 2020-07-23 |
| Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer Goserelin Acetate, Laboratory Biomarker Analysis, Leuprolide Acetate - Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7 | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 10 | 2010-07-09 | 2019-02-28 |
| Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy Goserelin Acetate, Laboratory Biomarker Analysis, Leuprolide Acetate - Prostate Adenocarcinoma, Stage IIA Prostate Cancer | Phase 2 | Terminated | Mayo Clinic | 16 | 2009-07-01 | 2019-12-27 |
| A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation Leuprolide acetate depot (LAD) 11.25 mg 3 Month, Matched placebo - Hodgkin Disease, Lymphoma, Non-Hodgkin | Phase 2 | Terminated | Abbott | 25 | 2006-02-01 | 2010-05-06 |
Prostatic Neoplasms (2) · Hodgkin Disease (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Abbott (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University of California, San Francisco (1)
United States (4)
Christopher Logothetis (1) · Rahul Aggarwal, MD (1) · Robert Karnes (1)
N01CM00039 (1), N01CM62202 (1), P30CA015083 (1), P30CA016672 (1), U01CA062461 (1), U01CA062491 (1)